Envision Pharma Group are double award winners – winning Gold and Silver at the PM Society Digital Awards
Envision has won gold and silver excellence awards for its work in collaboration with Mundipharma at the 10th anniversary of the PM Society Digital Awards.
The Mundipharma account team from Envision headed up to The Brewery, London on the 19th September to attend and await the outcome from the judges.
In recognition for its unique approach to digital creativity, the team scooped one Gold award for ‘Excellence in Congress, Meetings and Events’, along with a Silver for ‘Innovation – Creativity’.
Awards judge and Medical Director Joubert Gama said, “The team were really impressed with this entry, especially in terms of keeping with the theme of the congress which was sustainability. The technology was really well used and the insights gained from different customers were used to guide them for future materials.”
Multichannel Director at Envision Alex Watson added, “Envision Pharma Group are thrilled to have won both of these aspirational PM Society Digital Awards for our work in collaboration with Mundipharma.
“Bringing physical and tangible interactions to the unbound value of digital communication channels is not only a recipe for communication success for both us and our clients, but more importantly also for healthcare professionals who see real value in having information personalised to their interests and delivered in engaging and memorable ways.”
Now in its 10th year, the PM Society Digital Awards strive to recognise digital effectiveness, creativity and innovation within the healthcare industry – highlighting programmes, tools and campaigns across a range of digital activities.
There are 15 categories that are all judged over a two-stage process, with many of the judges working within the healthcare industry themselves, who are assisted by creative and digital experts.
Watson noted, “This is the first time Envision have entered the PM Society Digital Awards so to have achieved this accolade is testament to the talents and capabilities of our in-house team. Congratulations to all involved, and thank you Mundipharma for the opportunity.”
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving the pharmaceutical, biotechnology, and medical device industries. Envision is a leading provider of evidence communication services and industry leading technology solutions that have applicability across many areas of Medical Affairs and related functional responsibilities. Envision Pharma Group provides services and technology solutions to more than 80 companies, including 19 of the top 20 pharmaceutical companies.
Envision has 12 offices, five in the UK – Bishop’s Stortford, Horsham, London (Hammersmith), Marlow, and Wilmslow; one in Serbia; four in the US – Philadelphia, PA; Warren, NJ; Fairfield and Glastonbury, CT; and two in Asia Pacific – Tokyo and Sydney. The company employs more than 700 team members, including over 250 highly qualified in-house medical writers and over 140 technology solutions team members involved with software development and customer support.
Tel: +44 (0) 1279 656 656